General Information of Drug (ID: DM5UFZX)

Drug Name
Diazaborines Drug Info
Synonyms
KBPMSEXASFSGEI-WRBBICKQSA-N; Neomycin B-arginine conjugate; NeoR; AC1LAWYH; Hexaarginine-Neomycin B Conjugate; [D-Streptamine, O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1fwdarw4)-O-[O-2,6-diamino-2,6-dideoxy-beta-L-idopyranyl- (1fwdarw3)-beta-D-ribofuranosyl-(1fwdarw5)]-2-deoxy]-arginine
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
496913
TTD Drug ID
DM5UFZX

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [3]
Epigallocatechin gallate DMCGWBJ Hepatic fibrosis DB93.0 Phase 3 [4]
Nicotinamide-Adenine-Dinucleotide DM9LRKB N. A. N. A. Investigative [5]
Beta-D-Glucose DM5IHYP Discovery agent N.A. Investigative [5]
MORIN DM2OGZ5 Discovery agent N.A. Investigative [6]
3,7,3',4'-TETRAHYDROXYFLAVONE DMES906 Discovery agent N.A. Investigative [6]
(-)-CATECHINGALLATE DMZOGSK Discovery agent N.A. Investigative [6]
Thiolactomycin DMBAWDG Malaria 1F40-1F45 Investigative [3]
GALLOCATECHIN GALLATE DMX2084 Discovery agent N.A. Investigative [6]
ISORHAMNETIN DMQ4Z6E Discovery agent N.A. Investigative [6]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Chimeric small nucleolar RNA-TAR decoy DMJATBL Discovery agent N.A. Investigative [7]
2,4-diaminoquinozalines and quinoxaline-2,3-diones DMS1YXL Discovery agent N.A. Investigative [8]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Bacterial NADH-dependent enoyl-ACP reductase 1 (Bact fabI1) TTCH81V FABI1_RHIME Inhibitor [2]
Bacterial NADH-dependent enoyl-ACP reductase 2 (Bact fabI2) TT283NK FABI2_RHIME Inhibitor [2]
Human immunodeficiency virus TAR RNA (HIV TAR-RNA) TTNSXG2 NOUNIPROTAC Inhibitor [1]
Plasmodium Enoyl-ACP reductase (Malaria fabI) TTNX2CS Q965D5_PLAFA Inhibitor [2]

References

1 Neomycin B-arginine conjugate, a novel HIV-1 Tat antagonist: synthesis and anti-HIV activities. Biochemistry. 2001 Dec 25;40(51):15612-23.
2 Lipid biosynthesis as a target for antibacterial agents. Prog Lipid Res. 2001 Nov;40(6):467-97.
3 Novel molecular targets for antimalarial drug development. Chem Biol Drug Des. 2008 Apr;71(4):287-97.
4 Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR). J Med Chem. 2007 Feb 22;50(4):765-75.
5 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
6 Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids. J Med Chem. 2006 Jun 1;49(11):3345-53.
7 A nucleolar TAR decoy inhibitor of HIV-1 replication. Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14047-52.
8 RNA as a target for small molecules. Curr Opin Chem Biol. 2000 Dec;4(6):678-86.